2016-11-07T02-16-15Z
Source: International Journal of Current Research and Review
Md. Asad Iqubal, Mobeen Khan, Umesh Chandra Chaudhary, Swetarchi, Bushra Farhat, Nazish Akhtar.
Lichen planus is a mucocutaneous disease affecting approximately 1.5 to 2% of the world population. Oral lichen planus (OLP) is a chronic mucosal condition. It has various oral manifestations, the reticular form being the most common. The course of the disease is usually unpredictable with bouts of remission and exacerbation being common. The most widely accepted treatment for lesions of OLP involves topical or systemic corticosteroids to modulate the patients immune response.
http://ift.tt/2fSZDYm
Δευτέρα 7 Νοεμβρίου 2016
ORAL LICHEN PLANUS: AN UPDATE
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibrobl...
-
guide to thesis writing guide to thesis writing College Application Essay Pay Jmu Use your free time to prepare for an exam or meet with fri...
-
Essay Example, Outline, and Introduction Sample Here are the instructions you will see for the essay outline and introduction section of the...
-
Abstract Background We have previously published data from 2001 to 2006 showing that adolescent and young adult (AYA) oncology patients ...
-
by Mindaugas Paužuolis, Torsten Eich, Joachim Burman Background Natalizumab (NTZ) is a drug that has been widely used in the treatment of m...
-
REM sleep selectively prunes and maintains new synapses in development and learning. Nat Neurosci. 2017 Jan 16;: Authors: Li W, Ma L,...
-
Abstract Desmoplastic small round cell tumor (DSCRT) is a rare malignancy most often seen in the abdomen or pelvis of young men. Unfortuna...
-
by Jun Xu, Shuqing Chen, Baosheng Zeng, Anthony A. James, Anjiang Tan, Yongping Huang Manipulation of sex determination pathways in insect...
-
Abstract Purpose To develop the first photoactive biomaterial coating capable of controlled drug dosing via inclusion of synthesised drug-...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου